Kelyniam Global, Inc. (KLYG)

Market Cap	6.09M
Revenue (ttm)	2.67M
Net Income (ttm)	-218.47K
Shares Out	30.46M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.200
Previous Close	0.200
Day's Range	0.200 - 0.200
52-Week Range	0.040 - 0.290
Beta	-1.25
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 11, 2024

About Kelyniam Global

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Inv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: KLYG

Financial Performance

In 2023, Kelyniam Global's revenue was $2.67 million, a decrease of -11.44% compared to the previous year's $3.02 million. Losses were -$218,471, 123.9% more than in 2022.